Menopausal hormone therapy-ovarian cancer risk revisited

被引：2
|
作者：
Davis, Susan R. [1 ]
Baber, Rodney [2 ]
机构：
[1] Monash Univ, Sch Publ Hlth & Prevent Med, Womens Hlth Res Program, Melbourne, Vic 3004, Australia
[2] Univ Sydney, Royal N Shore Hosp, Sydney Med Sch North, Discipline Obstet Gynaecol & Neonatol, St Leonards, NSW 2065, Australia
来源：
NATURE REVIEWS ENDOCRINOLOGY | 2015年 / 11卷 / 06期
关键词：
D O I：
10.1038/nrendo.2015.33
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A large meta-analysis of 52 observational studies, conducted in multiple countries, suggests that menopausal hormone therapy (MHT) increases the risk of ovarian cancer. Should women who are taking MHT, either as estrogen alone or as estrogen combined with a progestogen, and their doctors be worried?
引用
收藏
页码：322 / 323
页数：2
相关论文
共 50 条
12345